| scholarly article | Q13442814 |
| P50 | author | Arjun Kakrani | Q81229618 |
| Navneet Agrawal | Q83199871 | ||
| P2093 | author name string | Anil Pareek | |
| Nihal Thomas | |||
| Alaka Deshpande | |||
| Vijay Viswanathan | |||
| Banshi Saboo | |||
| O P Gupta | |||
| Asha Shah | |||
| M Mahesh | |||
| Nitin Chandurkar | |||
| Sudhir Bhandari | |||
| Shrikant Sharma | |||
| Kunal Kothari | |||
| N K Thulasidharan | |||
| N B Vijaykumar | |||
| Shashidhar Devaramani | |||
| P2860 | cites work | Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseases | Q34354276 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hydroxychloroquine | Q421094 |
| type 2 diabetes | Q3025883 | ||
| P304 | page(s) | 1257-1266 | |
| P577 | publication date | 2014-05-02 | |
| P1433 | published in | Current Medical Research and Opinion | Q5195063 |
| P1476 | title | Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes mellitus: a double blind, randomized comparison with pioglitazone | |
| P478 | volume | 30 |
| Q38360827 | Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases |
| Q38845570 | Cooling down inflammation in type 2 diabetes: how strong is the evidence for cardiometabolic benefit? |
| Q54218397 | Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review. |
| Q92118099 | Dermatologists' Adherence to the Latest Recommendations for Screening of Hydroxychloroquine Retinopathy in Saudi Arabia: Cross-Sectional Study |
| Q95529015 | Drug approvals in India |
| Q92026856 | Expanding horizons for clinical applications of chloroquine, hydroxychloroquine, and related structural analogues |
| Q39144641 | Hydroxychloroquine's Efficacy as an Antiplatelet Agent Study in Healthy Volunteers: A Proof of Concept Study |
| Q38927961 | Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with Diabetes |
| Q90451569 | Potential Effect of Hydroxychloroquine in Diabetes Mellitus: A Systematic Review on Preclinical and Clinical Trial Studies |
| Q41916806 | The marketing of unproven drugs for diabetes and dyslipidaemia in India |
| Q51104578 | Use of Hydroxychloroquine Is Associated With Improved Lipid Profile in Rheumatoid Arthritis Patients. |
Search more.